Emerging reports lead scientists to study if Ozempic (semaglutide) changes how users feel after drinking alcohol, prompting ...

Millions of Americans have tried GLP-1 medications like Ozempic, Mounjaro and Wegovy, polls show, but pharmacy claims data show that many people stop taking them within less than one year. There are ...

An RN shares 7 signs your Ozempic dose may be too low or too high, plus daily habits that can improve results.

The Food and Drug Administration is warning people to be on the lookout for counterfeit Ozempic, the diabetes drug that many people use off-label for weight loss. The federal agency and Novo Nordisk, ...

Northwell Health reports that "Ozempic face" describes the facial changes from rapid weight loss using Ozempic, highlighting cosmetic concerns while noting they are not serious health risks.

Millions of people have lost weight on GLP-1s. But the drugs can also cause significant loss of muscle mass. The fitness industry is responding with tailored workouts that cater to these clients. The ...

Ozempic can flatten butts and maybe extinguish them, too! Taking Ozempic or its sister drug Wegovy may help some smokers kick the habit, new research suggests. The study compares the effects of eight ...

Zepbound and Ozempic are both prescription drugs part of the GLP-1 agonist drug class. While their uses are different, they do have some similarities, such as dosing schedule and form. This article ...

Side effects of Ozempic seem to be similar in males and females. Some evidence suggests that females may be more likely to have side effects from GLP-1 receptor agonists, but this hasn’t been ...

As prices for Ozempic have risen in recent months, many people may be seeking cheaper alternatives for managing diabetes or weight loss. Some doctors, along with the U.S. Food and Drug Administration ...

Ozempic (semaglutide) helps people with type 2 diabetes lower their blood sugar if diet, exercise, and other diabetes medications haven’t worked. If you’ve just gotten a prescription for it, you might ...